Obesity Clinical Trials

Find Obesity Clinical Trials Near You

Impact of Different Exercise Intensities and Durations on Systemic Inflammation - The ISAR InflEx Trial (Inflammation and Exercise) -

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A sedentary lifestyle and obesity are associated with chronic low-grade inflammation and an elevated risk of cardiovascular disease (CVD). This study aims to systematically characterize and compare the effects of three distinct exercise modalities - moderate-intensity, vigorous-intensity, and short-duration maximal exercise - each differing in duration and intensity, on systemic inflammation and immune function. The study investigates the potential of exercise as an effective anti-inflammatory intervention for the prevention of CVD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• BMI 25.0 - 30.0 kg/m²

• age 18 - 45 years

• informed consent

• no regular physical activity (≤1x/week of structured exercise)

• willingness to strictly follow and adhere to the intervention protocol for the entire study

Locations
Other Locations
Germany
German Heart Centre
RECRUITING
München
Contact Information
Primary
Hendrik B Sager, MD
hendrik.sager@tum.de
00498912184025
Time Frame
Start Date: 2026-01-01
Estimated Completion Date: 2027-06
Participants
Target number of participants: 33
Treatments
Experimental: first arm
first moderate-intensity exercise, second vigorous-intensity exercise, third short bouts of maximal exercise
Experimental: second arm
first vigorous-intensity exercise, second short bouts of maximal exercise, third moderate-intensity exercise
Experimental: third arm
first short bouts of maximal exercise, second moderate-intensity exercise, third vigorous-intensity exercise
Related Therapeutic Areas
Sponsors
Collaborators: Klinikum rechts der Isar Technische Universität München, The German Heart Foundation
Leads: Department of Cardiology German Heart Center Munich TUM University Hospital

This content was sourced from clinicaltrials.gov